SummaryThe high-affinity uptake of tritium labelled tryptophan (TRY), 5-hydroxytryptophan (5-HPT), 5-hydroxytryptamine (5-HT), noradrenaline (NE), dopamine (DA), glycine and glutamic acid into forebrain synaptosomes, and serum 5-HT concentrations were studied in mice. In vitro the rank order of potency (the concentration causing 50 percent uptake inhibition) of seven inhibitors of 5-HT uptake was paroxetine >citalopram > femoxetine >fluoxetine > alaproclate _->imipramine > zimelidine. Paroxetine was a weak inhibitor of the NE and DA uptake without any effect on the synaptosomal accumulation of TRY, 5-HTP, glycine or glutamic acid. Dose related inhibition of synaptosomal 5-HT uptake ex vivo was found one hour after intraperitoneal single dose administered paroxetine (EDs0 = 0.3 mg/kg i.p.) and 75% inhibition persisted 24 hours after 10 mg/kg i.p. (=ED100). Chronically administered paroxetine produced a slight decrement of synaptosomal NE uptake. Serum 5-HT concentrations were found dose dependently reduced during chronic paroxetine treatment. A dose level of paroxetine which reduced serum 5-HT concentrations with 50 % produced an almost complete inhibition of synaptosomal 5-HT uptake.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.